US Health Secretary Robert F. Kennedy Jr. touted to lawmakers the Trump administration’s use of artificial intelligence while defending sprawling agency cuts critics say hinder needed medical research and set back the US on the international stage.
“Even the initial introductions that we’re making with AI have already quickened the clinical trial process,” Kennedy told the Senate Appropriations’ Labor, Health, and Education Subcommittee Tuesday."I can’t even imagine the kind of opportunities that we’re going to get from this, from transitioning to AI and marrying that with biomedical research.”
Kennedy’s remarks came during a hearing on the Trump administration’s fiscal 2026 ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.